NR3C2 and stroke disorder: Mice deficient for the MR specifically in myeloid cells were protected against cardiac hypertrophy, fibrosis, and vascular damage in vivo (9, 36) and showed a reduced infarct volume and less cerebral inflammation in a model of stroke (23).